Teysuno
tegafur, gimeracil, oteracil
tegafur/gimeracil/oteracil
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
If you get any side effects, talk to your doctor. This includes any possible any side effects not listed in this leaflet. See section 4.
What Teysuno is and what it is used for
What you need to know before you take Teysuno
How to take Teysuno
Possible side effects
How to store Teysuno
Contents of the pack and other information
Teysuno contains the active substances tegafur gimeracil and oteracil.
Teysuno belongs to the fluoropyrimidine class of medicines known as “antineoplastic agents” which stop the growth of cancer cells.
Teysuno is prescribed by doctors for:
The treatment of adults with advanced stomach (gastric) cancer and is taken with cisplatin, another anti-cancer medicine.
The treatment of cancer of the large intestines and rectum which has spread (metastasized)
and where it is not possible to continue with another fluoropyrimidine (anti-cancer treatments from the same group of medicines as Teysuno) due to side effects on the skin of hands or feet (hand-foot syndrome) or on the heart. In these patients, Teysuno is used alone or in combination with other anticancer medicines.
are allergic to tegafur, gimeracil, oteracil or any of the other ingredients of this medicine (listed
in section 6).
are taking other fluoropyrimidine anti-cancer medicine such as fluorouracil and capecitabine, or have had severe and unexpected reactions to fluoropyrimidines
know that you do not have any activity of the enzyme dihydropyrimidine dehydrogenase (DPD)
(complete DPD deficiency)
are pregnant or breast-feeding
have severe blood disorders
have kidney disease requiring dialysis
are being treated now or have been treated in the last 4 weeks with brivudine as part of herpes zoster (chickenpox or shingles) therapy.
Talk to your doctor before taking Teysuno if you have:
blood disorders
kidney disease
stomach and/or bowel problems such as pain, diarrhoea, vomiting and dehydration
eye disorders, such as “dry eye” or increased tearing
a current or previous infection of the liver with the hepatitis B virus, since your doctor may want to monitor you more closely
a partial deficiency in the activity of the enzyme dihydropyrimidine dehydrogenase (DPD)
a family member who has partial or complete deficiency of the enzyme dihydropyrimidine dehydrogenase (DPD)
Teysuno is not recommended for children under 18 years of age.
Tell your doctor if you are taking, have recently taken or might take any other medicines.
Also, you need to be particularly careful if you are taking any of the following:
other fluoropyrimidine based medicines such as the anti-fungal flucytosine. Teysuno cannot be substituted for other oral fluoropyrimidine medicine.
inhibitors of the enzyme CYP2A6 which activates Teysuno such as tranylcypromine and methoxsalen
folinic acid (often used in chemotherapy with methotrexate)
blood-thinning medicines: coumarin-derivative anticoagulants such as warfarin
medicines for the treatment of seizures or tremors such as phenytoin
medicines that treat gout such as allopurinol
Teysuno should be taken at least one hour before or one hour after a meal.
Before starting treatment, you must tell your doctor or pharmacist if you are pregnant, if you think you are pregnant, or if you intend to become pregnant. You must not take Teysuno if you are pregnant or think you might be.
During and up to 6 months after treatment with Teysuno, you must use contraceptive measures. If you become pregnant during this time, you must tell your doctor.
You must not breastfeed if you are taking Teysuno.
Ask your doctor or pharmacist for advice before taking any medicine.
Use caution when driving or operating a machine, as Teysuno may make you tired, nauseous or have blurred vision. If you have any doubts talk to your doctor.
sugars, contact your doctor before taking this medicine.
Always take Teysuno exactly as your doctor has told you. You should check with your doctor if you are not sure.
Your doctor will tell you what dose you need to take, when to take it and for how long you need to take it. Your dose of Teysuno will be determined by your doctor based on your height and weight. Your doctor may reduce the dose if you have side effects that are too severe.
Teysuno capsules should be swallowed with water at least 1 hour before or 1 hour after a meal. Teysuno must be taken twice daily (morning and evening).
For stomach cancer:
Teysuno capsules are usually taken for 21 days followed by a 7 day rest period (when no capsules are taken). This 28 day period is one treatment cycle. The cycles are repeated.
Teysuno will be given with another anti-cancer medicine called cisplatin. Cisplatin will be stopped after 6 treatment cycles. Teysuno can be continued after stopping cisplatin.
For cancer of the large intestines or rectum that has spread:
Teysuno capsules are usually taken for 14 days followed by a 7 day rest period (when no capsules are taken). This 21 day period is one treatment cycle. The cycles are repeated.
Teysuno can be given with other anti-cancer medicines (cisplatin, oxaliplatin, irinotecan or bevacizumab), which will depend on your treatment.
If you take more capsules than you should, contact your doctor immediately.
Do not take the missed dose at all and do not take a double dose to make up for a forgotten dose. Instead, continue your regular dosing schedule and check with your doctor.
There are no side effects caused by stopping treatment with Teysuno. In case you are using blood thinning or anti-seizure medicines, stopping Teysuno might require that your doctor adjusts the dose of your medicines.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, Teysuno can cause side effects, although not everybody gets them. While some symptoms are easily identified as side effects by the patients themselves, a blood test is required to identify some other symptoms. Your doctor will discuss this with you and will explain the possible risks and benefits of the treatment.
-Diarrhoea, nausea, vomiting, constipation
If you experience diarrhoea more than 4 times a day or in the middle of the night, or if you experience sore mouth accompanied by diarrhoea, stop taking Teysuno and contact your doctor immediately.
If you experience diarrhoea, avoid high-fibre, fatty and spicy foods.
Take plenty of liquids between meals to replace lost fluids and prevent dehydration, low
blood volume, and imbalance of salts or chemicals in the blood.
If you experience nausea and vomit a dose of medication, make sure you tell your doctor.
Do not replace the dose that has been vomited.
If you vomit more than two times in 24 hours, stop taking Teysuno and contact your doctor immediately.
To help manage nausea and vomiting:
Lie down or take deep breaths when feeling nauseous
Avoid tight clothing
You may have symptoms such as cold hands and feet, looking pale, light-headedness, fatigue, breathlessness.
If you experience any of the above-mentioned symptoms, try not to work too hard and get ample sleep and rest.
You may have symptoms such as fever, chills, coughing, sore throat.
If you have fever of 38.5o C or higher, stop taking Teysuno and contact your doctor immediately.
To prevent infection, keep away from crowded places, gargle upon returning home, and wash your hands before meals and before and after using the bathroom.
If you have bleeding of the skin, mouth (caused by brushing teeth), nose, respiratory tract, stomach, gut, etc., stop taking Teysuno and contact your doctor immediately.
To prevent bleeding, avoid hard work or strenuous sports so as to prevent injuries and bruises. Wear loose clothing to protect the skin. Brush your teeth and blow your nose gently.
You may become dehydrated if you do not eat and/or drink enough water.
If you become dehydrated you may have symptoms such as dry mouth, weakness, dry skin, dizziness, cramping
Try to eat frequent small meals. Avoid fatty and strong-smelling food. Even if you do not feel hungry, continue to eat as much as you can to maintain good nutrition.
If you feel tired and have fever together with loss of appetite, contact your doctor immediately.
difficulty, disorder of the salivary gland, haemorrhoids
site, cancer pain and bleeding, multiple organ failure
acute liver failure
pancreas infection
muscle breakdown
loss of sense of smell
sun allergy
widespread blood clotting and bleeding
disease affecting the white matter of the brain
serious illness with blistering of the skin, mouth and genitals
recurrence (reactivation) of hepatitis B infection when you have had hepatitis B in the past (a liver infection)
If you experience any of the side effects or if you notice any side effects not listed in this leaflet, please tell your doctor.
If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the outer carton and blister after
EXP. The expiry date refers to the last day of the month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substances are tegafur, gimeracil and oteracil.
Each hard capsule contains 15 mg tegafur, 4.35 mg gimeracil, and 11.8 mg oteracil (as monopotassium).
The other ingredients are:
Capsule contents: lactose monohydrate, magnesium stearate
Capsule shell: gelatin, red iron oxide (E172), titanium dioxide (E171), sodium lauryl sulphate, talc
Ink: red iron oxide (E172), yellow iron oxide (E172), Indigo carmine (E132), carnauba wax, bleached shellac, glyceryl monooleate
The hard capsules have a white body and opaque brown cap imprinted "TC448" in grey. They are provided in blisters containing 14 capsules each.
Each pack contains either 42 capsules, 84 capsules or 126 capsules.
Nordic Group B.V. Siriusdreef 41
2132 WT Hoofddorp
The Netherlands
2132 WT Hoofddorp The Netherlands
Millmount Healthcare Limited Block7, City North
Business Campus, Stamullen Co. Meath, K32 YD60 Ireland
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
België/Belgique/Belgien Nordic Pharma
Tél/Tel: +32 (0)3 820 5224
Lietuva
Nordic Pharma (France)
Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28
00
AMRING FARMA SRL, Tel. : +40 31 620 1204
RO.OfficeRomania@nordicpharma.com
Nordic Pharma
Tél/Tel: +32 (0)3 820 5224
Tel: +420 241 080 770
Nordic Drugs
Tlf: +46 (0)40 36 66 00
Malta
Nordic Pharma (France) Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28 00 info@nordicpharma.com
Nordic Pharma
Tel: +49 (0)89 889 690 680
Nordic Pharma BV
Tel: +31 (0)85 48 35 871
Eesti
Nordic Pharma (France) Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28
Aenorasis S.A.
Τηλ: +30 210 6136332
Nordic Drugs
Tlf: +46 40-36 66 00
Nordic Pharma
Tel: +49 (0)89 889 690 680
España
Nordic Pharma (France) Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28
AMRING FARMA SRL, Tel. : +40 31 620 1204
RO.OfficeRomania@nordicpharma.com
France
Nordic Pharma (France) Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28
Hrvatska
Nordic Pharma (France) Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28
Nordic Pharma Ireland Tel: +353 (0)1 400 4141
Portugal
Nordic Pharma (France) Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28 00 info@nordicpharma.com
AMRING FARMA SRL, Tel. : +40 31 620 1204
RO.OfficeRomania@nordicpharma.com
NORDIC Pharma, s.r.o. Tel.: +420 241 080 770
Vistor hf.
Sími: +354 535 7000
Italia
Nordic Pharma
Tel: +39 (0)2 241 26710/26711
Nordic Drugs
Puh/Tel: +358 (0)10 231 1040
Nordic Pharma (France) Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28
Latvija
Nordic Pharma (France)
Tel/Τηλ/Tél/Tel.: +33 (0)1 70 37 28
Nordic Drugs AB
Tel: +46 (0)40 36 66 00
Nordic Pharma Ireland Tel: +353 (0)1 400 4141
Detailed information this medicine is available on the European Medicines Agency web site: .